CG Oncology (CGON) Change in Receivables (2024 - 2026)
CG Oncology (CGON) posted Change in Receivables of $587000.0 for Q1 2026, up 95.02% on a QoQ basis from $301000.0 in Q4 2025, and up 234.63% year-over-year from $175416.0 in Q1 2025.
CG Oncology (CGON) Change in Receivables (2024 - 2026) Analysis & Trends
CG Oncology's Change in Receivables history runs 3 years deep, the most recent figure standing at $587000.0 for Q1 2026.
- Quarterly Change in Receivables rose 234.63% year-over-year to $587000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $320000.0, down 53.56% from the prior year.
- Change in Receivables was $587000.0 for Q1 2026 at CG Oncology, up from $301000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $644000.0 in Q4 2024 and bottomed at -$436000.0 in Q1 2025.
- A 3-year average of $215142.9 and a median of $238000.0 in 2025 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 628.89% in 2025, while the deepest fall reached 53.26% in 2025.
- CG Oncology's Change in Receivables stood at $644000.0 in 2024, then slumped by 53.26% to $301000.0 in 2025, then soared by 95.02% to $587000.0 in 2026.
- Business Quant data shows CGON's Change in Receivables at $587000.0 in Q1 2026, $301000.0 in Q4 2025, and $238000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn | 587,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 587,000.00 |
| Mar 31, 2026 | 587,000.00 |
| Dec 31, 2025 | 301,000.00 |
| Dec 31, 2025 | 301,000.00 |
| Sep 30, 2025 | 238,000.00 |
| Sep 30, 2025 | 238,000.00 |
| Jun 30, 2025 | 217,000.00 |
| Jun 30, 2025 | 217,000.00 |
| Mar 31, 2025 | -436,000.00 |
| Mar 31, 2025 | -436,000.00 |
| Dec 31, 2024 | 644,000.00 |
| Dec 31, 2024 | 644,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Sep 30, 2024 | -45,000.00 |